Press release
Systemic Lupus Erythematous (SLE) Drugs Market Size, Industry Trends, Share and Forecast 2021-2027
The global systemic lupus erythematous (SLE) drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease that causes the immune system to attack healthy body tissue. In SLE, the body immune system can affect any part of the body, such as joints, organs, eyes, skin, among others. The major factor for the growth of the market during the forecast period is the high prevalence of autoimmune diseases, particularly systemic lupus erythematous (SLE).According to the Lupus Foundation of America, 1.5 million Americans, and at least five million people have a form of lupus globally. Additionally, lupus strikes mostly women of childbearing age. However, men, children, and teenagers can also develop lupus. Further, as per the same source, almost 90% of people living with lupus are women and most people develop the disease between the ages of 15-44. Apart from this, there are 16,000 new cases of lupus every year.
To Request a Sample of our Report on Systemic Lupus Erythematous (SLE) Drugs Market: https://www.omrglobal.com/request-sample/systemic-lupus-erythematous-sle-drugs-market
Some major key players in the market include Bristol-Myers Squibb Co., GlaxoSmithKline plc, and Sanofi S.A., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, GlaxoSmithKline plc received approval for BENLYSTA (belimumab) by the FDA for the treatment of adult patients with active lupus nephritis. Lupus nephritis is a serious inflammation of the kidneys caused by systemic lupus erythematosus (SLE).
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Product
· By Distribution Channel
• Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape-Bristol-Myers Squibb Co., GlaxoSmithKline plc,and Sanofi S.A., among others.
(Get 15% Discount on Buying this Report)
A full Report of Systemic Lupus Erythematous (SLE) Drugs Market is Available at: https://www.omrglobal.com/industry-reports/systemic-lupus-erythematous-sle-drugs-market
Global Systemic Lupus Erythematous (SLE) Drugs Market Report by Segment
By Product
• Corticosteroids
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Anti-Inflammatories
• Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
• Antimalarials
• BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)
• Immunosuppressive Agents/Immune Modulators
• Anticoagulants
By Distribution Channel
• Hospital Pharmacies
• Drug Stores
• Online Drug Stores
Global Systemic Lupus Erythematous (SLE) Drugs Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Systemic Lupus Erythematous (SLE) Drugs Market Size, Industry Trends, Share and Forecast 2021-2027 here
News-ID: 2549724 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for SLE
Systemic Lupus Erythematosus (SLE) Market Detailed Industry Report Analysis 2025 …
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the immune system attacks multiple organ systems, including skin, joints, kidneys, and blood vessels. It is often unpredictable, with flare-ups and remissions that complicate management. Symptoms range from fatigue and skin rashes to life-threatening organ damage.
While conventional treatments such as corticosteroids, antimalarials, and immunosuppressants remain central, recent years have seen significant advances with biologics, targeted therapies, and precision medicine approaches.…
Systemic Lupus Erythematous SLE Drugs Market Professional Survey Report 2015-202 …
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc. Often SLE can result in symptoms such as malar rash, discoid lesions, sub-acute cutaneous lesions, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurologic involvement, thrombocytopenia, haemolytic anemia, fever, Raynaud’s phenomenon, livedo reticularis,…
Systemic lupus erythematosus (SLE) Market: Analysis and Segment Forecasts To 20 …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025
In terms of geography, North America accounts for the dominant share in terms of revenue owing to advancements in the treatment of systemic lupus erythematosus and rising awareness among people about the disease. Europe accounts for the second largest market in terms of revenue due to high incidence rate of SLE and increase in research activities in the field of systemic lupus erythematosus. The Asia Pacific market is also witnessing…
Systemic lupus erythematosus (SLE) Market Report by Regional Analysis : forecast …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Global Resuscitation Ventilators Market 2017 : Eternity, SIRIUSMED, Siare & SLE
The survey report by Market Research Store is an overview of the global Resuscitation Ventilators market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Resuscitation Ventilators market trends along with the projections of CAGRs (compound annual growth rates) are provided in the research report.
Further, an evaluation of the history of the global market and the basic…
